ID SOLUTIONS

ID SOLUTIONS is a biotechnology startup founded in 2016. The company specializes in offering comprehensive Molecular Typing Assays using DigitalPCR for Oncology Diagnostics. Their slogan "ID SOLUTIONS offers comprehensive Molecular Typing Assays using DigitalPCR for Oncology Diagnostics" underscores their core focus. The company's mission is to provide innovative, reliable, and standardized tools for oncology diagnostics, with research focusing on circulating DNA from liquid biopsy and tumor DNA from solid biopsies. The team comprises molecular biology specialists with over 20 years of expertise in nucleic acid extraction, molecular biology, and oncology, highlighting their depth of experience. ID SOLUTIONS aims to offer a complete molecular typing solution, standardized operating procedures, and custom development to enhance diagnosis in oncology. While further details about the company's headquarter, last investment, and investors are not available, their dedication to advancing oncology diagnostics through innovative molecular typing assays is evident. The company operates within the Biotechnology, Health Care, and Manufacturing industries, positioning themselves at the forefront of innovation in these sectors.